Clinical Trials Logo

Clinical Trial Summary

The purpose of this early feasibility study is to investigate the outcome of selected patients with ascending thoracic aortic pathologies including type A aortic dissection, who are suitable for endovascular repair with the Medtronic Valiant PS-IDE Stent Graft System with the Captivia Delivery System (or the Valiant PS-IDE Stent Graft).


Clinical Trial Description

The purpose of this early feasibility study is to investigate the outcome of selected patients with ascending aortic pathologies including type A aortic dissection, retrograde type A aortic dissection, who are suitable for endovascular repair with the Valiant PS-IDE Stent Graft device. The investigators propose to study patients with Dissections affecting the aorta between the Sinus of Valsalva and the innominate artery orifice (with no involvement of aortic valve). In these patients, the ascending aorta will be repaired using the stent graft. For patients with type A aortic dissection, the investigators expect to reroute the blood to the true lumen by covering the proximal tear. In patients with retrograde type A aortic dissection, there might or might not be additional tears in the ascending aorta. If they are tears in ascending aorta, these dissections behave similarly like a type A aortic dissection, in which all the tears in the ascending aorta need to be covered. If the proximal tear is only in the descending thoracic aorta, these patients will require coverage in the ascending aorta with the stent graft along with coverage of proximal tear in the descending thoracic aorta using Valiant stent graft. Patients will be selected from a high-risk surgical cohort. The total number of enrolled subjects is planned to be 20. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03322033
Study type Interventional
Source Baylor Research Institute
Contact Megan C White, BA
Phone 469-814-4720
Email megan.white1@bswhealth.org
Status Recruiting
Phase N/A
Start date December 15, 2018
Completion date January 15, 2028

See also
  Status Clinical Trial Phase
Recruiting NCT05639569 - Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
Completed NCT01369732 - Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest Phase 4
Completed NCT02190487 - Incidence and Risk Factors of Acute Kidney Injury After Thoracic Aortic Surgery Due to Dissection N/A
Active, not recruiting NCT05030740 - French Assessment of the Relay Plus and Relay NBS Plus Thoracic Stent-Graft